Company Overview of Psyadon Pharmaceuticals, Inc.
Psyadon Pharmaceuticals, Inc. engages in the discovery and development of drugs for the treatment of diseases afflicting the central nervous system, primarily neurological and psychiatric diseases. Its Ecopipam product is an antagonist of the D1 dopamine receptor that blocks the actions of the neurotransmitter dopamine at the D1 receptor-family in the brain. Psyadon Pharmaceuticals, Inc. was formerly known as Ruxton Pharmaceuticals, Inc. and changed its name in November 2008. The company was founded in 2004 and is based in Germantown, Maryland.
20451 Seneca Meadows Parkway
Germantown, MD 20876
Founded in 2004
Key Executives for Psyadon Pharmaceuticals, Inc.
Psyadon Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Ischemix, Inc.||United States|
|Blue Note Pharmaceuticals, Inc.||United States|
|Rapamycin Holdings, Inc.||United States|
|Pure Essence Laboratories, Inc.||United States|
|Emergent Product Development Gaithersburg, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Psyadon Pharmaceuticals, Inc., please visit www.psyadonrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.